Literature DB >> 29730850

Grooming a CAT: customizing CAT administration rules to increase response efficiency in specific research and clinical settings.

Michael A Kallen1, Karon F Cook2, Dagmar Amtmann3, Elizabeth Knowlton2, Richard C Gershon2.   

Abstract

PURPOSE: To evaluate the degree to which applying alternative stopping rules would reduce response burden while maintaining score precision in the context of computer adaptive testing (CAT). DATA: Analyses were conducted on secondary data comprised of CATs administered in a clinical setting at multiple time points (baseline and up to two follow ups) to 417 study participants who had back pain (51.3%) and/or depression (47.0%). Participant mean age was 51.3 years (SD = 17.2) and ranged from 18 to 86. Participants tended to be white (84.7%), relatively well educated (77% with at least some college), female (63.9%), and married or living in a committed relationship (57.4%). The unit of analysis was individual assessment histories (i.e., CAT item response histories) from the parent study. Data were first aggregated across all individuals, domains, and time points in an omnibus dataset of assessment histories and then were disaggregated by measure for domain-specific analyses. Finally, assessment histories within a "clinically relevant range" (score ≥ 1 SD from the mean in direction of poorer health) were analyzed separately to explore score level-specific findings.
METHOD: Two different sets of CAT administration rules were compared. The original CAT (CATORIG) rules required at least four and no more than 12 items be administered. If the score standard error (SE) reached a value < 3 points (T score metric) before 12 items were administered, the CAT was stopped. We simulated applying alternative stopping rules (CATALT), removing the requirement that a minimum four items be administered, and stopped a CAT if responses to the first two items were both associated with best health, if the SE was < 3, if SE change < 0.1 (T score metric), or if 12 items were administered. We then compared score fidelity and response burden, defined as number of items administered, between CATORIG and CATALT.
RESULTS: CATORIG and CATALT scores varied little, especially within the clinically relevant range, and response burden was substantially lower under CATALT (e.g., 41.2% savings in omnibus dataset).
CONCLUSIONS: Alternate stopping rules result in substantial reductions in response burden with minimal sacrifice in score precision.

Entities:  

Keywords:  CAT stopping rules; Computer adaptive testing; PROMIS®; Response burden

Mesh:

Year:  2018        PMID: 29730850     DOI: 10.1007/s11136-018-1870-z

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  23 in total

1.  Item response theory and health outcomes measurement in the 21st century.

Authors:  R D Hays; L S Morales; S P Reise
Journal:  Med Care       Date:  2000-09       Impact factor: 2.983

Review 2.  Dynamic assessment of health outcomes: time to let the CAT out of the bag?

Authors:  Karon F Cook; Kimberly J O'Malley; Toni S Roddey
Journal:  Health Serv Res       Date:  2005-10       Impact factor: 3.402

Review 3.  Systematic reviews of therapeutic interventions frequently consider patient-important outcomes.

Authors:  Hayet Ameur; Philippe Ravaud; Florence Fayard; Carolina Riveros; Agnes Dechartres
Journal:  J Clin Epidemiol       Date:  2017-01-29       Impact factor: 6.437

4.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

5.  Using classical test theory, item response theory, and Rasch measurement theory to evaluate patient-reported outcome measures: a comparison of worked examples.

Authors:  Jennifer Petrillo; Stefan J Cano; Lori D McLeod; Cheryl D Coon
Journal:  Value Health       Date:  2015-01       Impact factor: 5.725

6.  Sleep-wake functioning along the cancer continuum: focus group results from the Patient-Reported Outcomes Measurement Information System (PROMIS(®)).

Authors:  Kathryn E Flynn; Rebecca A Shelby; Sandra A Mitchell; Maria R Fawzy; N Chantelle Hardy; Aatif M Husain; Francis J Keefe; Andrew D Krystal; Laura S Porter; Bryce B Reeve; Kevin P Weinfurt
Journal:  Psychooncology       Date:  2010-10       Impact factor: 3.894

7.  Applications of computerized adaptive testing (CAT) to the assessment of headache impact.

Authors:  John E Ware; Mark Kosinski; Jakob B Bjorner; Martha S Bayliss; Alice Batenhorst; Carl G H Dahlöf; Stewart Tepper; Andrew Dowson
Journal:  Qual Life Res       Date:  2003-12       Impact factor: 4.147

8.  Progress in assessing physical function in arthritis: PROMIS short forms and computerized adaptive testing.

Authors:  James F Fries; David Cella; Matthias Rose; Eswar Krishnan; Bonnie Bruce
Journal:  J Rheumatol       Date:  2009-09       Impact factor: 4.666

9.  Development and psychometric analysis of the PROMIS pain behavior item bank.

Authors:  Dennis A Revicki; Wen-Hung Chen; Neesha Harnam; Karon F Cook; Dagmar Amtmann; Leigh F Callahan; Mark P Jensen; Francis J Keefe
Journal:  Pain       Date:  2009-08-15       Impact factor: 6.961

10.  Minimally important differences for Patient Reported Outcomes Measurement Information System pain interference for individuals with back pain.

Authors:  Dagmar Amtmann; Jiseon Kim; Hyewon Chung; Robert L Askew; Ryoungsun Park; Karon F Cook
Journal:  J Pain Res       Date:  2016-04-27       Impact factor: 3.133

View more
  2 in total

1.  Customizing CAT Administration of the PROMIS Misuse of Prescription Pain Medication Item Bank for Patients with Chronic Pain.

Authors:  Dokyoung S You; Karon F Cook; Benjamin W Domingue; Maisa S Ziadni; Jennifer M Hah; Beth D Darnall; Sean C Mackey
Journal:  Pain Med       Date:  2021-07-25       Impact factor: 3.750

2.  Comparison of Patient-Reported Outcomes Measurement Information System Computerized Adaptive Testing Versus Fixed Short Forms in Juvenile Myositis.

Authors:  Ruchi N Patel; Valeria G Esparza; Jin-Shei Lai; Elizabeth L Gray; Bryce B Reeve; Rowland W Chang; David Cella; Kaveh Ardalan
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-07-30       Impact factor: 5.178

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.